Showing 1 - 5 results of 5 for search 'James W. Hodge', query time: 0.02s Refine Results
  1. 1
    A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance

    A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance by Ginette S. Santiago-Sánchez, Kellsye P. Fabian, James W. Hodge

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing

    Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing by Jeffrey Schlom, James W Hodge, Benjamin Wolfson, Michelle R Padget

    Published 2021-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines

    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines by Renee N Donahue, Jeffrey Schlom, James L Gulley, James W Hodge, Claudia Palena, Duane H Hamilton, Sofia R Gameiro

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models

    Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models by James W Hodge, Howard Kaufman, Michelle R Padget, Kellsye P Fabian, Sailaja Battula, Wiem Lassoued, Ginette Santiago-Sanchez, Clint Tanner Allen

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations

    PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations by Jeffrey Schlom, James W Hodge, Clint T. Allen, Shahrooz Rabizadeh, Patrick Soon-Shiong, John H. Lee, Renee N. Donahue, Kristen Solocinski, Michelle R Padget, Kellsye P Fabian, Yvette Robbins

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: